2Dawson LA,Normolle D,Balter JM,et al.Analysis of radia- tion-induced liver disease using the Lyman NTCP model [J].Int J Radiat Oncol BioI Phys,2002,53(4):810-821.
3Rusthoven KE,Kavanagh BD,Cardenes H,et al.Multi-institu- tional phase I/II trial of stereotactic body radiation therapy for liver metastases[J].J Clin Oncol,2009,27(10):1572-1578.
4Scorsetti M,Clerici E,Comito T.Stereotactic body radiation therapy for liver metastases[J].J Gastrointest Oncol,2014,5(3):190-197.
5Scorsetti M,Arcangeli S,Tozzi A,et al.Is stereotactic body radi- ation therapy an attractive option for unresectable liver metasta- ses? A preliminary report from a phase 2 trial[J].Int J Radiat Oncol Biol Phys,2013,86(2):336-342.
6Chang DT,Swaminath A,Kozak M,et al.Stereotactic body ra- diotherapy for colorectal liver metastases:a pooled analysis [J].Cancer,2011,117(17):4060-4069.
7Giammarile F,Bodei L,Chiesa C,et al.EANM procedure guide- line for the treatment of liver cancer and liver metastases with in- tra-arterial radioactive compounds [J].Eur J Nucl Med Mol Im- aging,2011,38(7):1393-1406.
8Kalva SP,Thabet A,Wicky S.Recent advances in transarterial therapy of primary and secondary liver malignancies [J].Radio- graphics,2008,28(1):101-117.
